Status:

UNKNOWN

Evaluation of the Efficacy of Artemisinin Combination Therapy in Kenya

Lead Sponsor:

Sabah Ahmed Omar

Collaborating Sponsors:

World Bank

Kenya Medical Research Institute

Conditions:

Malaria

Eligibility:

All Genders

6-10 years

Phase:

PHASE3

Brief Summary

Artemisinin-based combination therapies (ACTs) are recommended for use against uncomplicated malaria in areas of multi-drug resistant malaria. The Ministry of Health, Division of Malaria Control (DOMC...

Eligibility Criteria

Inclusion

  • Age between 6 months - 5 years (in high endemic areas); 6 months to 10 years (in low endemic areas) inclusive.
  • Presence of axillary temperature \> 37.5oC or rectal / tympanic temp \> 38.0oC, or history of fever in the last 24 hours.
  • Monoinfection with Plasmodium falciparum with parasitaemia, asexual parasitemia between 2,000 - 200,000 p/µl (in areas of high transmission); 1,000-100,000p/ µl (in areas of low to moderate malaria transmission)
  • Ability and willingness to comply with the study protocol for the duration of the study and to comply with the study visit schedule; and
  • Signed informed consent form by the parents or legal guardian.

Exclusion

  • Presence of clinical danger signs: not able to drink or breast-feed, vomiting (\>twice in 24 hours), recent history of convulsions (\>1 in 24h), unconscious state, unable to sit or stand;
  • Mixed or mono-infection with another Plasmodium species detected by microscopy;
  • Presence of co-morbid infection (e.g. acute lower respiratory tract infection, severe diarrhoea with dehydration, Severe Anaemia) or other known underlying chronic or severe diseases (e.g. cardiac, renal and hepatic diseases,Epilepsy, HIV/AIDS);
  • History of hypersensitivity reactions or contraindications to any of the medicine(s) being tested or used as alternative treatment(s).

Key Trial Info

Start Date :

April 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2015

Estimated Enrollment :

2100 Patients enrolled

Trial Details

Trial ID

NCT01899820

Start Date

April 1 2013

End Date

July 1 2015

Last Update

October 8 2013

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

Busia district hospitals

Busia, Busia County, Kenya

2

Kisii district hospitals

Kisii, Kisii County, Kenya

3

Kitale district hospitals

Kitale, Kitale, Kenya

4

Msambweni sub-district hospital

Msambweni, Kwale County, Kenya